Kucur, S. Et Al. 2015. How medical treatment affects mean platelet volume as a cardiovascular risk marker in polycystic ovary syndrome?. BLOOD COAGULATION & FIBRINOLYSIS , vol.26, no.8 , 862-865.

Kucur, S., Gozukara, I., Aksoy, A., Uludag, E. U., Keskin, H., Kamalak, Z., ... Carlioglu, A.(2015). How medical treatment affects mean platelet volume as a cardiovascular risk marker in polycystic ovary syndrome?. BLOOD COAGULATION & FIBRINOLYSIS , vol.26, no.8, 862-865.

Kucur, SUNA Et Al. "How medical treatment affects mean platelet volume as a cardiovascular risk marker in polycystic ovary syndrome?," BLOOD COAGULATION & FIBRINOLYSIS , vol.26, no.8, 862-865, 2015

Kucur, SUNA K. Et Al. "How medical treatment affects mean platelet volume as a cardiovascular risk marker in polycystic ovary syndrome?." BLOOD COAGULATION & FIBRINOLYSIS , vol.26, no.8, pp.862-865, 2015

Kucur, S. Et Al. (2015) . "How medical treatment affects mean platelet volume as a cardiovascular risk marker in polycystic ovary syndrome?." BLOOD COAGULATION & FIBRINOLYSIS , vol.26, no.8, pp.862-865.

@article{article, author={SUNA KABİL KUCUR Et Al. }, title={How medical treatment affects mean platelet volume as a cardiovascular risk marker in polycystic ovary syndrome?}, journal={BLOOD COAGULATION & FIBRINOLYSIS}, year=2015, pages={862-865} }